Antimicrobial usage among hospitalized children in Latvia: a neonatal and pediatric antimicrobial point prevalence

Inese Sviestina1, Dzintars Mozgis2

  • 1University Children's Hospital, Riga, Latvia; Faculty of Pharmacy, Riga Stradins University, Riga, Latvia.

Insights

This study analyzed antibiotic prescribing in Latvian hospitals, finding high use of certain cephalosporins and parenteral antibiotics in children. Improvements are needed in antibiotic guidelines and prophylaxis duration.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Hospital Pharmacy

Background:

  • The Antibiotic Resistance and Prescribing in European Children (ARPEC) Project aimed to assess antimicrobial use in pediatric populations.
  • Understanding current prescribing patterns is crucial for developing targeted quality improvement strategies.

Purpose of the Study:

  • To analyze pediatric and neonatal antimicrobial prescribing patterns in Latvian hospitals.
  • To identify areas for quality improvement in pediatric antibiotic use.

Main Methods:

  • A one-day, cross-sectional point prevalence survey was conducted in 10 Latvian hospitals in November 2012.
  • All inpatient pediatric and neonatal beds were included, identifying children on antimicrobial treatment.

Main Results:

  • 549 patients were included; 39% of pediatric and 21% of neonatal patients received antimicrobials.
  • Third-generation cephalosporins were most prescribed for pediatric patients; benzylpenicillin and gentamicin for neonates.
  • Lower respiratory tract infections were the most common indication; parenteral administration and prolonged surgical prophylaxis were frequent.

Conclusions:

  • High use of third-generation cephalosporins and parenteral antibiotics requires attention.
  • Prolonged surgical prophylaxis and lack of local antibiotic guidelines are areas for improvement.
  • Targeted interventions are needed to optimize pediatric antimicrobial prescribing in Latvia.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
395
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
972
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
74
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
532
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
62